300+ investors in your industry, stage, and region Get
Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Poland
Puerto Rico
Colombia
Guernsey
Cameroon
Armenia
China
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Angola
Albania
Europe
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Cyprus
Spain
Mongolia
Qatar
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Brookline Venture Partners, VC Fund

Brookline Venture Partners

VC Fund

Cambridge, United States

Brookline Venture Partners is a VC fund in Cambridge focused on Security and Software. Brookline Venture Partners was founded in 2004 to invest in early-stage companies. Its founders are entrepreneurs with operational, financial, and sales experience. BVP partners Ken Levine and Mark Goodman bring a wealth of experience to their portfolio companies, providing strategic and tactical advice to management teams as they navigate thenumerous challenges facing start-up companies.

Total investments:
7
Last investment:
Lead investor:
29%

Last updated:

Industries Brookline Venture Partners invests in

SecuritySoftwareEnterprise SoftwareSaaSHealth Care

Stages Brookline Venture Partners invests in

Series BSeries ASeries CSeries DFunding Round

Countries Brookline Venture Partners invests in

United States

Contacts

NameEmailPhoneSocials
Kenneth Levine Kenneth Levine

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Security 2 (29%)
  • Software 2 (29%)
  • Enterprise Software 2 (29%)
  • SaaS 1 (14%)
  • Health Care 1 (14%)
See all 11 industries →

Stage

  • Series B 2 (29%)
  • Series A 1 (14%)
  • Series C 1 (14%)
  • Series D 1 (14%)
  • Funding Round 1 (14%)
See all 6 stages →

Team

NameTitleInvestmentsLinksEmail
Kenneth Levine
Kenneth Levine Co-founder and Partner
Co-founder and Partner Total investments: 2
Find email

Investments

CompanyDescriptionRoundLinks
Digital Guardian Digital Guardian
Digital Guardian provides the industry’s only data protection platform that is purpose-built to stop data theft from both insiders and external adversaries. The Digital Guardian Data Protection Platform performs across the corporate network, traditional endpoints, and cloud applications. It's buttressed by the DG Cloud, a big data securityanalytics backend that sees and blocks all threats to sensitive information. For more than 15 years, it has enabled data-rich organizations to protect their most valuable assets with a choice of on premises, SaaS or managed service deployment. Digital Guardian’s unique data awareness, combined with threat detection and response, enables organizations to protect data without slowing the pace of their business.It was founded in 2003 and is headquartered in Waltham, Massachusetts, United States. $30M / Private Equity / Apr 24, 2019
TRACON Pharmaceuticals TRACON Pharmaceuticals
TRACON develops targeted therapies for cancer utilizing a capital efficient, CRO independent, product development platform. The Company’s clinical-stage pipeline includes: Envafolimab, a PD-L1 single-domain antibody given by rapid subcutaneous injection that is being studied in the pivotal ENVASARC trial for sarcoma; TRC102, a Phase 2 smallmolecule drug candidate for the treatment of lung cancer; and TJ004309, a CD73 antibody in Phase 1 development for the treatment of advanced solid tumors. TRACON is actively seeking additional corporate partnerships whereby it leads U.S. regulatory and clinical development, shares in the cost and risk of clinical development, and leads U.S. commercialization. In these partnerships TRACON believes it can serve as a solution for companies without clinical and commercial capabilities in the United States. $27M / Series B / Sep 22, 2014
TRACON Pharmaceuticals TRACON Pharmaceuticals
TRACON develops targeted therapies for cancer utilizing a capital efficient, CRO independent, product development platform. The Company’s clinical-stage pipeline includes: Envafolimab, a PD-L1 single-domain antibody given by rapid subcutaneous injection that is being studied in the pivotal ENVASARC trial for sarcoma; TRC102, a Phase 2 smallmolecule drug candidate for the treatment of lung cancer; and TJ004309, a CD73 antibody in Phase 1 development for the treatment of advanced solid tumors. TRACON is actively seeking additional corporate partnerships whereby it leads U.S. regulatory and clinical development, shares in the cost and risk of clinical development, and leads U.S. commercialization. In these partnerships TRACON believes it can serve as a solution for companies without clinical and commercial capabilities in the United States. $14M / Series A / Apr 20, 2011
NitroSecurity NitroSecurity
NitroSecurity is a supplier of Unified Information Security solutions that provide Edge-to-Core network security for enterprises across many vertical markets, including healthcare, education, financial services, government, retail, hospitality, and managed services. Leveraging patented data management technology, NitroSecurity delivers anintegrated, cost effective network security product suite for security information & event management, log management, database activity monitoring, network analysis and intrusion prevention. $6M / Oct 11, 2010
NitroSecurity NitroSecurity
NitroSecurity is a supplier of Unified Information Security solutions that provide Edge-to-Core network security for enterprises across many vertical markets, including healthcare, education, financial services, government, retail, hospitality, and managed services. Leveraging patented data management technology, NitroSecurity delivers anintegrated, cost effective network security product suite for security information & event management, log management, database activity monitoring, network analysis and intrusion prevention. $10M / Series D / Aug 19, 2008
NitroSecurity NitroSecurity
NitroSecurity is a supplier of Unified Information Security solutions that provide Edge-to-Core network security for enterprises across many vertical markets, including healthcare, education, financial services, government, retail, hospitality, and managed services. Leveraging patented data management technology, NitroSecurity delivers anintegrated, cost effective network security product suite for security information & event management, log management, database activity monitoring, network analysis and intrusion prevention. $2M / Series C / Sep 27, 2006
NitroSecurity NitroSecurity
NitroSecurity is a supplier of Unified Information Security solutions that provide Edge-to-Core network security for enterprises across many vertical markets, including healthcare, education, financial services, government, retail, hospitality, and managed services. Leveraging patented data management technology, NitroSecurity delivers anintegrated, cost effective network security product suite for security information & event management, log management, database activity monitoring, network analysis and intrusion prevention. $6.5M / Series B / Feb 25, 2005

Co-Investors

First Analysis First Analysis 4 deals together
NewSpring Ventures NewSpring Ventures 2 deals together
Nextech Invest Nextech Invest 2 deals together
Arcus Ventures Arcus Ventures 2 deals together
BioMed Ventures BioMed Ventures 1 deal together
General Electric Pension Trust General Electric Pension Trust 1 deal together

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Poland
Puerto Rico
Colombia
Guernsey
Cameroon
Armenia
China
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Angola
Albania
Europe
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Cyprus
Spain
Mongolia
Qatar
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Brookline Venture Partners invest in?

Brookline Venture Partners invests primarily in Security, Software and Enterprise Software startups, most often at Series B and Series A stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Brookline Venture Partners?

Public channels for Brookline Venture Partners include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Brookline Venture Partners?

The team at Brookline Venture Partners includes Kenneth Levine (Co-founder and Partner). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Brookline Venture Partners Brookline Venture Partners Find emails